Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$13.01
At close: May 7 EDT
$14.00
0.997.61%
Pre-Market: 8:30 AM EDT
Comments
Loading...
Ardent Health Partners Analyst Ratings and Price Targets | NYSE:ARDT | Benzinga
Ardent Health Partners Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Ardent Health Partners Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Guggenheim
Mizuho
Stephens & Co.
RBC Capital
Stephens & Co.
1calculated from analyst ratings
Analyst Ratings for Ardent Health Partners
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/09/2025 | Buy Now | — | Guggenheim | Jason Cassorla52% | → $16 | Initiates | → Buy | Get Alert |
| 04/09/2025 | Buy Now | — | Mizuho | Ann Hynes86% | $19 → $18 | Maintains | Outperform | Get Alert |
| 04/01/2025 | Buy Now | — | Stephens & Co. | Scott Fidel 45% | $22 → $22 | Reiterates | Overweight → Overweight | Get Alert |
| 03/26/2025 | Buy Now | — | Stephens & Co. | Scott Fidel 45% | $22 → $22 | Reiterates | Overweight → Overweight | Get Alert |
| 03/04/2025 | Buy Now | — | RBC Capital | Ben Hendrix60% | $23 → $21 | Maintains | Outperform | Get Alert |
| 02/27/2025 | Buy Now | — | Stephens & Co. | Raj Kumar 49% | $22 → $22 | Reiterates | Overweight → Overweight | Get Alert |
| 01/21/2025 | Buy Now | — | Morgan Stanley | Craig Hettenbach59% | $23.5 → $22 | Maintains | Overweight | Get Alert |
| 01/06/2025 | Buy Now | — | Truist Securities | David Macdonald67% | $22 → $21 | Maintains | Buy | Get Alert |
| 12/17/2024 | Buy Now | — | JP Morgan | Benjamin Rossi59% | → $20 | Assumes | → Neutral | Get Alert |
| 11/14/2024 | Buy Now | — | RBC Capital | Ben Hendrix60% | $23 → $23 | Reiterates | Outperform → Outperform | Get Alert |
| 11/12/2024 | Buy Now | — | Leerink Partners | Whit Mayo66% | $23 → $25 | Maintains | Outperform | Get Alert |
| 11/06/2024 | Buy Now | — | B of A Securities | Kevin Fischbeck67% | $22 → $19 | Downgrade | Buy → Neutral | Get Alert |
| 10/11/2024 | Buy Now | — | Keybanc | Matthew Gillmor65% | → $24 | Initiates | → Overweight | Get Alert |
| 09/19/2024 | Buy Now | — | Stephens & Co. | Scott Fidel69% | $24 → $24 | Reiterates | Overweight → Overweight | Get Alert |
| 08/16/2024 | Buy Now | — | Truist Securities | David Macdonald67% | $21 → $22 | Reiterates | Buy → Buy | Get Alert |
| 08/16/2024 | Buy Now | — | Loop Capital | Timothy Greaves26% | $18 → $21 | Maintains | Buy | Get Alert |
| 08/15/2024 | Buy Now | — | Stephens & Co. | Scott Fidel69% | $24 → $24 | Reiterates | Overweight → Overweight | Get Alert |
| 08/12/2024 | Buy Now | — | B of A Securities | Kevin Fischbeck67% | → $22 | Initiates | → Buy | Get Alert |
| 08/12/2024 | Buy Now | — | RBC Capital | Ben Hendrix60% | → $23 | Initiates | → Outperform | Get Alert |
| 08/12/2024 | Buy Now | — | Citigroup | — | → $21 | Initiates | → Buy | Get Alert |
| 08/12/2024 | Buy Now | — | Loop Capital | Timothy Greaves26% | → $18 | Initiates | → Buy | Get Alert |
| 08/12/2024 | Buy Now | — | Leerink Partners | Whit Mayo66% | → $23 | Initiates | → Outperform | Get Alert |
| 08/12/2024 | Buy Now | — | JP Morgan | Lisa Gill58% | → $18 | Initiates | → Neutral | Get Alert |
| 08/12/2024 | Buy Now | — | Truist Securities | David Macdonald67% | → $21 | Initiates | → Buy | Get Alert |
| 08/12/2024 | Buy Now | — | Mizuho | Ann Hynes86% | → $20 | Initiates | → Outperform | Get Alert |
| 08/12/2024 | Buy Now | — | Morgan Stanley | Craig Hettenbach59% | → $27 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Ardent Health Partners (ARDT) stock?
The latest price target for Ardent Health Partners (NYSE:ARDT) was reported by Guggenheim on April 9, 2025. The analyst firm set a price target for $16.00 expecting ARDT to rise to within 12 months (a possible 14.29% upside). 26 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ardent Health Partners (ARDT)?
The latest analyst rating for Ardent Health Partners (NYSE:ARDT) was provided by Guggenheim, and Ardent Health Partners initiated their buy rating.
When was the last upgrade for Ardent Health Partners (ARDT)?
There is no last upgrade for Ardent Health Partners
When was the last downgrade for Ardent Health Partners (ARDT)?
The last downgrade for Ardent Health Partners Inc happened on November 6, 2024 when B of A Securities changed their price target from $22 to $19 for Ardent Health Partners Inc.
When is the next analyst rating going to be posted or updated for Ardent Health Partners (ARDT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ardent Health Partners, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ardent Health Partners was filed on April 9, 2025 so you should expect the next rating to be made available sometime around April 9, 2026.
Is the Analyst Rating Ardent Health Partners (ARDT) correct?
While ratings are subjective and will change, the latest Ardent Health Partners (ARDT) rating was a initiated with a price target of $0.00 to $16.00. The current price Ardent Health Partners (ARDT) is trading at is $14.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
